HyNOVA at Lifehouse
29/03/2022
In the video, Dr Farrell discusses the HyNOVA trial at Chris O’Brien Lifehouse.
The first HyNOVA participant was successfully randomised last week 👏
HyNOVA is a randomised study comparing hyperthermic/normothermic chemotherapy for stage III epithelial ovarian, fallopian tube & primary peritoneal cancer.
More about HyNOVA 👇@TrialsCentre @COBLH pic.twitter.com/zW8G7GEkxR
— ANZGOG (@anzgog) March 29, 2022
